vs
传奇娱乐(ACEL)与Healthpeak Properties(DOC)财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是传奇娱乐的2.0倍($702.9M vs $351.6M),Healthpeak Properties净利率更高(51.6% vs 4.2%,领先47.5%),传奇娱乐同比增速更快(8.5% vs -6.6%),过去两年传奇娱乐的营收复合增速更高(6.6% vs 0.5%)
传奇娱乐是一家美国大众传媒与电影制作公司,总部位于加利福尼亚州伯班克,由托马斯·图尔于2000年创立。该公司长期与华纳兄弟影业、环球影业、索尼影视、派拉蒙影业等主流制片厂,以及网飞、葫芦等流媒体平台展开合作。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金,核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建,总部设在科罗拉多州丹佛市,在尔湾、纳什维尔、旧金山均设有办事处,截至2019年12月31日共持有617处物业的权益。
ACEL vs DOC — 直观对比
营收规模更大
DOC
是对方的2.0倍
$351.6M
营收增速更快
ACEL
高出15.2%
-6.6%
净利率更高
DOC
高出47.5%
4.2%
两年增速更快
ACEL
近两年复合增速
0.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $351.6M | $702.9M |
| 净利润 | $14.7M | $363.0M |
| 毛利率 | — | — |
| 营业利润率 | 7.7% | 0.7% |
| 净利率 | 4.2% | 51.6% |
| 营收同比 | 8.5% | -6.6% |
| 净利润同比 | 0.3% | 28.3% |
| 每股收益(稀释后) | — | $0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACEL
DOC
| Q1 26 | $351.6M | $702.9M | ||
| Q4 25 | $341.4M | $719.4M | ||
| Q3 25 | $329.7M | $705.9M | ||
| Q2 25 | $335.9M | $694.3M | ||
| Q1 25 | $323.9M | $702.9M | ||
| Q4 24 | $317.5M | $698.0M | ||
| Q3 24 | $302.2M | $700.4M | ||
| Q2 24 | $309.4M | $695.5M |
净利润
ACEL
DOC
| Q1 26 | $14.7M | $363.0M | ||
| Q4 25 | $16.2M | $114.0M | ||
| Q3 25 | $13.4M | $-117.1M | ||
| Q2 25 | $7.3M | $31.7M | ||
| Q1 25 | $14.6M | $42.8M | ||
| Q4 24 | $8.4M | $4.5M | ||
| Q3 24 | $4.9M | $85.9M | ||
| Q2 24 | $14.6M | $146.0M |
毛利率
ACEL
DOC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 58.6% | ||
| Q2 25 | — | 60.2% | ||
| Q1 25 | — | 61.1% | ||
| Q4 24 | — | 60.3% | ||
| Q3 24 | — | 60.0% | ||
| Q2 24 | — | 60.6% |
营业利润率
ACEL
DOC
| Q1 26 | 7.7% | 0.7% | ||
| Q4 25 | 8.7% | 17.4% | ||
| Q3 25 | 7.7% | 9.2% | ||
| Q2 25 | 8.0% | 5.7% | ||
| Q1 25 | 8.0% | 7.7% | ||
| Q4 24 | 6.5% | -2.2% | ||
| Q3 24 | 7.2% | 14.1% | ||
| Q2 24 | 7.3% | 22.3% |
净利率
ACEL
DOC
| Q1 26 | 4.2% | 51.6% | ||
| Q4 25 | 4.7% | 73.2% | ||
| Q3 25 | 4.1% | -16.6% | ||
| Q2 25 | 2.2% | 4.6% | ||
| Q1 25 | 4.5% | 6.1% | ||
| Q4 24 | 2.6% | 0.7% | ||
| Q3 24 | 1.6% | 12.3% | ||
| Q2 24 | 4.7% | 21.0% |
每股收益(稀释后)
ACEL
DOC
| Q1 26 | — | $0.28 | ||
| Q4 25 | $0.19 | $0.16 | ||
| Q3 25 | $0.16 | $-0.17 | ||
| Q2 25 | $0.08 | $0.05 | ||
| Q1 25 | $0.17 | $0.06 | ||
| Q4 24 | $0.09 | $0.02 | ||
| Q3 24 | $0.06 | $0.12 | ||
| Q2 24 | $0.17 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $274.1M | $-1.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $272.3M | $7.8B |
| 总资产 | $1.1B | $21.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ACEL
DOC
| Q1 26 | $274.1M | $-1.2B | ||
| Q4 25 | $296.6M | $467.5M | ||
| Q3 25 | $290.2M | $91.0M | ||
| Q2 25 | $264.6M | $89.4M | ||
| Q1 25 | $271.9M | $70.6M | ||
| Q4 24 | $281.3M | $119.8M | ||
| Q3 24 | $265.1M | $180.4M | ||
| Q2 24 | $254.9M | $106.9M |
总债务
ACEL
DOC
| Q1 26 | — | — | ||
| Q4 25 | $607.4M | $9.8B | ||
| Q3 25 | $595.4M | $9.1B | ||
| Q2 25 | $595.5M | $9.0B | ||
| Q1 25 | $580.7M | $8.9B | ||
| Q4 24 | $595.4M | $8.7B | ||
| Q3 24 | $554.1M | $8.6B | ||
| Q2 24 | $565.7M | $8.6B |
股东权益
ACEL
DOC
| Q1 26 | $272.3M | $7.8B | ||
| Q4 25 | $269.7M | $7.5B | ||
| Q3 25 | $267.1M | $7.6B | ||
| Q2 25 | $260.5M | $7.9B | ||
| Q1 25 | $259.1M | $8.2B | ||
| Q4 24 | $255.0M | $8.4B | ||
| Q3 24 | $206.7M | $8.6B | ||
| Q2 24 | $209.1M | $8.8B |
总资产
ACEL
DOC
| Q1 26 | $1.1B | $21.6B | ||
| Q4 25 | $1.1B | $20.3B | ||
| Q3 25 | $1.1B | $19.6B | ||
| Q2 25 | $1.1B | $19.8B | ||
| Q1 25 | $1.0B | $19.8B | ||
| Q4 24 | $1.0B | $19.9B | ||
| Q3 24 | $950.2M | $20.0B | ||
| Q2 24 | $950.3M | $20.2B |
负债/权益比
ACEL
DOC
| Q1 26 | — | — | ||
| Q4 25 | 2.25× | 1.31× | ||
| Q3 25 | 2.23× | 1.20× | ||
| Q2 25 | 2.29× | 1.14× | ||
| Q1 25 | 2.24× | 1.08× | ||
| Q4 24 | 2.33× | 1.04× | ||
| Q3 24 | 2.68× | 1.00× | ||
| Q2 24 | 2.71× | 0.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $42.7M | — |
| 自由现金流经营现金流 - 资本支出 | $20.2M | — |
| 自由现金流率自由现金流/营收 | 5.8% | — |
| 资本支出强度资本支出/营收 | — | 3.4% |
| 现金转化率经营现金流/净利润 | 2.92× | — |
| 过去12个月自由现金流最近4个季度 | $64.2M | — |
8季度趋势,按日历期对齐
经营现金流
ACEL
DOC
| Q1 26 | $42.7M | — | ||
| Q4 25 | $31.1M | $1.3B | ||
| Q3 25 | $55.2M | $315.0M | ||
| Q2 25 | $19.8M | $363.5M | ||
| Q1 25 | $44.8M | $279.4M | ||
| Q4 24 | $13.5M | $1.1B | ||
| Q3 24 | $50.1M | $318.2M | ||
| Q2 24 | $28.9M | $316.2M |
自由现金流
ACEL
DOC
| Q1 26 | $20.2M | — | ||
| Q4 25 | $16.0M | $357.0M | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $-6.2M | — | ||
| Q1 25 | $18.0M | — | ||
| Q4 24 | $2.1M | $333.7M | ||
| Q3 24 | $33.1M | — | ||
| Q2 24 | $11.4M | — |
自由现金流率
ACEL
DOC
| Q1 26 | 5.8% | — | ||
| Q4 25 | 4.7% | 49.6% | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | -1.9% | — | ||
| Q1 25 | 5.6% | — | ||
| Q4 24 | 0.7% | 47.8% | ||
| Q3 24 | 11.0% | — | ||
| Q2 24 | 3.7% | — |
资本支出强度
ACEL
DOC
| Q1 26 | — | 3.4% | ||
| Q4 25 | 4.4% | 124.4% | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 8.3% | — | ||
| Q4 24 | 3.6% | 105.6% | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 5.7% | — |
现金转化率
ACEL
DOC
| Q1 26 | 2.92× | — | ||
| Q4 25 | 1.92× | 10.99× | ||
| Q3 25 | 4.13× | — | ||
| Q2 25 | 2.71× | 11.48× | ||
| Q1 25 | 3.06× | 6.52× | ||
| Q4 24 | 1.62× | 235.43× | ||
| Q3 24 | 10.23× | 3.71× | ||
| Q2 24 | 1.98× | 2.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACEL
| Illinois | $252.8M | 72% |
| Montana (1) | $40.6M | 12% |
| Nevada | $29.3M | 8% |
| Nebraska | $11.4M | 3% |
| Louisiana | $10.1M | 3% |
| Georgia | $6.2M | 2% |
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |